Propeller Health has partnered with US pharmacy benefits manager Express Scripts to provide Propeller’s inhaler monitoring platform to asthma and COPD patients enrolled in Express Scripts’ Pulmonary Care Value Program. According to the companies, patients enrolled in a pilot program run by Express Scripts significantly improved adherence and used rescue inhalers 80% less often.
In addition to allowing for patient self-monitoring through an app, Propeller sensors upload inhaler usage data to the Express Scripts Pulmonary Therapeutic Resource Center which monitors patients’ inhaler use. If Express Scripts sees that a patient is underusing a maintenance inhaler or overusing a rescue inhaler, the patient is contacted by a pulmonary pharmacist for personalized counseling.
Express Scripts Senior VP and Chief Innovation Officer Glen Stettin said, “Our vision is to help patients with asthma or COPD understand and proactively manage their condition, allowing them to breathe easier day in and day out. Propeller Health’s success in sensor technology empowers patients and enables our pulmonary pharmacists to provide the best care for patients.”
Propeller co-founder and CEO David Van Sickle commented, “We’re excited to partner with Express Scripts to bring the benefits of digital medicine and connected respiratory care to their members. With data and guidance from Propeller, members can expect to improve self-management and to receive timely, supportive assistance from the clinical respiratory team at Express Scripts.”
Read the Propeller Health press release.
